The contribution of keratinocytes in capecitabine-stimulated hand-foot-syndrome

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

Mark S. Roh, Linda H. Colangelo, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2009 · 942 citations · Full text

Medicine, Oncology, Surgery +17

The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide‐induced apoptosis: significance for the molecular mechanism of Bcl‐2 action

Paolo Pinton · The EMBO Journal · 2001 · 592 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post et al. · The Lancet Oncology · 2012 · 507 citations

Medicine, Oncology, Chemotherapy +12

Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients

Lise Boussemart, Émilie Routier, Céu Mateus et al. · Annals of Oncology · 2013 · 205 citations · Full text

Medicine, Dermatology, Pharmacology +11

Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo.

Tamara Wrone-Smith, Thomas Cary Johnson, B.Dean Nelson et al. · PubMed · 1995 · 147 citations

Medicine, Dermatology, Molecular Biology +11